Fractionation in medium dose rate brachytherapy of cancer of the cervix

International Journal of Radiation Oncology Biology Physics

Volumn 35, Issue 5, 1996, Pages 907-914

  Leborgne, Felix ^a,c   Fowler, Jack F ^b   Leborgne, Joséh ^a   Zubizarreta, Eduardo ^a   Chappell, Rick ^b  

^a Hospital Italiano Montevideo   (Uruguay)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c NONE   (Uruguay)

Author keywords

Brachytherapy; Cancer of the cervix; Medium dose rate

Indexed keywords

ADULT; AGED; ARTICLE; BEAM THERAPY; BLADDER CARCINOMA; BRACHYTHERAPY; CANCER SIZE; CANCER STAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CARCINOMA; RECURRENT CANCER; UTERINE CERVIX CARCINOMA;

EID: 0030586010     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(96)00184-8     Document Type: Article

References (31)

1. 1. Barendsen, G. W. Dose fractionation, dose rate and iso-effect relationships for normal tissue response. Int. J. Radiat. Oncol. Biol. Phys. 8:1981-1997; 1982.
2. 2. Clark, B. G.; Souhami, L.; Roman, T. N.; Evans, M. D. C.; Pal, C. Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high dose rate br achy therapy: A dosimetric analysis. Int. J. Radiat. Oncol. Biol. Phys. 28:1243-1250; 1994.
3. 3. Dinshaw, K. A.; Shrivastava, S. K.; Muckaden, M. A.; Sharma, V.; Deore, S. D.; Viswanathan, S. P. Factors influencing treatment strategies using MDR brachytherapy for cervical cancer. In: Mould, R. F.; Batterman, J. J.; Martinez, A. A.; Speiser, B, L., eds. Brachytherapy from radium to optimization. Veenendaal, The Netherlands: Nucletron International, B.V.; 1994:67-78.
4. 4. Dusenberry, K. E.; Carson, L. F.; Potish, R. A. Perioperative morbidity and mortality of gynecological brachytherapy. Cancer 67:2786-2790; 1991.
5. 5. Eifel, P. J.; Levenback, C.; Oswald, M. J. The time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 30(Suppl. 1):212; 1994.
6. 6. Fowler, J. F. The linear quadratic formula and progress in fractionated radiotherapy. A review. Br. J. Radiol. 62:679-694; 1989.
7. 7. Haie-Meder, C.; Kramar, A.; Lambin, P.; Lancar, R.; Scalliet, P.; Bouzy, J.; Gerbaulet, A. Analysis of complications in a prospective randomised trial comparing two brachytherapy low dose rates in cervical carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 29:953-960; 1994.
8. 8. Hall, E. J.; Brenner, D. J. The dose rate effect in interstitial brachytherapy: A controversy resolved. Br. J. Radiol. 65:242-247; 1992.
9. 9. Hamberger, A. D.; Fletcher, G. H.; Wharton, J. T. Results of treatment of early stage I carcinoma of the uterine cervix with interacavity radium alone. Cancer 41:980-985; 1978.
10. 10. Horiot, J. C.; Fric, D.; Barillot, I.; Pigneux, J.; Schraub, S.; Pourquier, H.; DaIy, N.; Bolla, M.; Rozan, R.; Barthelme, R.; Keiling, R. Carcinoma of the cervix treated with radiotherapy alone: Results and prevention of complications. In: Mould, R. F.; Batterman, J. J.; Martinez, A. A.; Speiser, B. L., eds. Brachytherapy from radium to optimization. Veenendaal, The Netherlands: Nucletron International B.V.; 1994:79-90.
11. 11. Hunter, R. D. Dose rate correction in LDR intracavitary therapy. In: Mould, R. F.; Batterman, J. J.; Martinez, A. A.; Speiser, B. L., eds. Brachytherapy from radium to optimization. Veenendaal, The Netherlands: Nucletron International B.V.; 1994:55-59.
12. 12. Kaplan, E.; Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-481; 1958.
13. 13. Kim, R. Y.; Salter, M. M.; Weppelmann, B.; Brascho, D. J. Analysis of treatment modalities and their failures in stage 1b cancer of the cervix. Int. J. Radiat. Oncol. Biol. Phys. 155:834-835; 1988.
14. 14. Kottmeier, H. L. Complications following radiation therapy in carcinoma of the cervix and their treatment. Am. J. Obstet. Gynecol. 88:854-866; 1964.
15. 15. Lambin, P.; Gerbaulet, A.; Kramar, A.; Scalliet, P.; Haie-Meder, C.; Malaise, E. P.; Chassagne, D. Phase 111 trial comparing two low dose rates in brachytherapy of cervix carcinoma: Report at two years. Int. J. Radiat. Oncol. Biol. Phys. 25:405-412; 1993.
16. 16. Leborgne, F.; Mangarelli, E.; Leborgne, J. H. Radioterapia del cancer de cuello uterine. Rev. Int. Radiol. 3:135-149; 1978.
17. 17. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50:163-170; 1969.
18. 18. Mazeron, J. J.; Simon, J. M.; Le Pechoux, C.; Piedbois, P.; Le Bourgeois, J. P.; Pierquin, B. Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of the mobile tongue and floor of mouth with indium-192. Radiother. Oncol. 21:39-47; 1991.
19. 19. Montana, G. S.; Fowler, W. C. Carcinoma of the cervix: Analysis of bladder and rectal radiation dose and complications. Int. J. Radiat. Oncol. Biol. Phys. 16:95-100; 1989.
20. 20. Montana, G. S.; Martz, K. L.; Hanks, G. E. Patterns and sites of failure in cervix cancer treated in the USA in 1978. Int. J. Radiat. Oncol. Biol. Phys. 20:95-100; 1991.
21. 21. Patel, F. D.; Sharma, S. C.; Negi, P. S.; Ghoshal, S.; Gupta, B. D. Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: A clinical trial. Int. J. Radiat. Oncol. Biol. Phys. 28:335-341; 1994.
22. 22. Pederson, D.; Bentzen, S. M.; Overgaard, J. Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix. Int. J. Radiat. Biol. Phys. 29:941-952; 1994.
23. 23. Pederson, D.; Bentzen, S. M.; Overgaard, J. Reporting radiotherapeutic complications in patients with uterine cervical cancer. The importance of latency and classification systems. Radiother. Oncol. 28:134-141; 1993.
24. 24. Perez, C. A. Uterine cervix: Results of therapy. In: Perez, C. A.; Brady, L. W., eds. Principles and practice of radiation oncology. 2nd ed. Philadelphia, PA: J. B. Lippincott Co.; 1992:1167-1185.
25. 25. Perez, C.A.; Breaux, S.; Bedwinek, J. M.; Madoc-Jones, H.; Camel, H. M.; Purdy, J. A.; Waltz, B. J. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II Analysis of complications. Cancer 54:235-246; 1984.
26. 26. Ferez, C. A.; Breaux, S.; Madock-Jones, H.; Camel, M.; Purdy, J.; Sharmer, S.; Powers, W. E. Correlation between radiation dose and tumor recurrence and complications in carcinoma of the uterine cervix: Stages I and Ua. Int. J. Radiat. Oncol. Biol. Phys. 5:373-382; 1979.
27. 27. Sarkaria, J. N.; Petereit, D. G.; Stitt, J.; Hartman, T.; Chappell, R.; Thomadsen, B. R.; Buchler, D. A.; Fowler, J. F.; Kinsella, T. J. A comparison of the efficacy and complication rates of low dose-rate vs. high dose-rate brachytherapy in the treatment of uterine cervical carcinoma. Int. J. Radiat. Biol. Phys. 30:75-82; 1994.
28. 28. Speiser, B. Advantages of high dose rate remote afterloading systems: Physics or biology. Int. J. Radiat. Biol. Phys. 20:1133-1135; 1991.
29. 29. Stitt, J. A.; Fowler, J. F.; Thomadsen, B. R.; Buchler, D. A.; Paliwal, B. P.; Kinsella, T. J. High dose rate intracavitary brachytherapy for carcinoma of the cervix: The Madison system: I. Clinical and radiobiological considerations. Int. J. Radiat. Oncol. Biol. Phys. 24:335-348; 1992.
30. 30. Stout, R.; Hunter, R. D. Clinical trials of changing dose-rate in intracavitary low dose-rate therapy. In: Mould, R. F., ed. Brachytherapy 2. Veenendaal, The Netherlands: Nucletron International, B. V.; 1989:219-222.
31. 31. Tod, M.; Meredith, W. J. Treatment of cancer of the cervix uteri: A revised "Manchester Method." Br. J. Radiol. 26:252-257; 1953.